{"id":409639,"date":"2021-01-06T10:03:15","date_gmt":"2021-01-06T15:03:15","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=409639"},"modified":"2021-01-06T10:03:15","modified_gmt":"2021-01-06T15:03:15","slug":"constellation-pharmaceuticals-to-present-at-j-p-morgan-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/constellation-pharmaceuticals-to-present-at-j-p-morgan-healthcare-conference\/","title":{"rendered":"Constellation Pharmaceuticals to Present at J.P. Morgan Healthcare Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p>CAMBRIDGE,\u00a0Mass., Jan.  06, 2021  (GLOBE NEWSWIRE) &#8212; Constellation Pharmaceuticals, Inc. (Nasdaq: CNST) today announced that\u00a0Jigar Raythatha, CEO, will present a company overview at the\u00a0J.P. Morgan Healthcare Conference\u00a0at 10:50 AM EST\u00a0on\u00a0Thursday, January 14, 2021. A live audio webcast of the presentation and archive for replay will be available on the Investor Relations section of Constellation\u2019s website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=7PwxVPPzfIzvbzNJQWIN3Q2eMCBp6ruNptXBuR2Ny5iZ4MlTRIMPnxeAY9jsYXEm-gne6WKGCp2X6YZb6oX1inSYN3pAAMNFs_X17sxcLdQ1-eDCqyxODSEQR-Ggw6TWET3BOxhH6RSG219LrSx96eypBHOyKe4FZj9kFFMIT_VvbqcCzOOya8oSDDiJbTY8BI0C2jR-AdltUvPKUnzpvwLZEmwMcIuCLwHUp4ChX7i7noFIbLIsj7_f1YppGqw1uHVTe5UOJ7CbuUGEOpnnEREkr5poEx5oNhxj8Wj1pWdZ5f9ddU7Bquo13hZSlw73hSXtkDNYuCVeVCnUmC8DIFimddeTRqzXlro9guK4Sr-BkF59pkJUwr9eqQUaPSDP1G1sUd75w_zmbyitoUkdnJ1V6xqCXmlzya2z2eGxVH2PMMTc41i7KCbe7yBvnnzANEK7x21OCS26CVPKsJwu4Q==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>http:\/\/ir.constellationpharma.com\/events-and-presentations\/events<\/u><\/a>. The audio webcast replay will be available for 30 days following the live presentation.<\/p>\n<p>\n        <strong>About Constellation Pharmaceuticals<\/strong>\u00a0<\/p>\n<p>Constellation Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel therapeutics that selectively modulate gene expression to address serious unmet medical needs in patients with cancer. The Company has a deep understanding of how epigenetic and chromatin modifications in cancer cells and in the tumor and immune microenvironment play a fundamental role in driving disease progression and drug resistance. Constellation is driving development of the BET inhibitor CPI-0610 for the treatment of myelofibrosis as well as the EZH2 inhibitor\u00a0CPI-0209 for the treatment of\u00a0solid tumors. The Company is also applying its broad research and development capabilities to explore other novel targets that directly and indirectly impact gene expression to fuel a sustainable pipeline of innovative small-molecule product candidates.<\/p>\n<p>\n        <strong>Contacts<\/strong>\n      <\/p>\n<p>Kia Khaleghpour, Ph.D.<br \/>Vice President,\u00a0Investor Relations\u00a0and Communications<br \/>Constellation Pharmaceuticals<br \/>+1 617-844-6859<br \/><u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=asfUDEXLUsRwkAcxvNtTbbNyz2-lMYxu0ZuyPgIlVl7xBLXlFGu4p_p0W9ySOqBSYfw1j-PQyfvTXVQ0nlqrsgGyoXCtvsUJ-bnq7BKhp7cFhWwrAuh-zTS4fnSY_FDts48f_xUGwDUBK9lM7DoAmA==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">kia.khaleghpour@constellationpharma.com<\/a><\/u><\/p>\n<p>Lauren Arnold<br \/>Media Relations<br \/>MacDougall Biomedical Communications<br \/>+1 781-235-3060<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2_WDNQy80rn0H5mDPfZTEpRH0vtUz9lgaqSP8utGrkEYEAfz_tvZFsGUcQacbEZ-XVfmRg3nkgzHaWQV3g5I4HFaU5MpSEHx7v0RaTYB4BI=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>larnold@macbiocom.com<\/u><\/a><\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTUzMiMzOTA3MTIyIzIxMjA4NjA=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/4d9c08d7-9e4a-4cfb-94cf-5433bd1115cd\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>CAMBRIDGE,\u00a0Mass., Jan. 06, 2021 (GLOBE NEWSWIRE) &#8212; Constellation Pharmaceuticals, Inc. (Nasdaq: CNST) today announced that\u00a0Jigar Raythatha, CEO, will present a company overview at the\u00a0J.P. Morgan Healthcare Conference\u00a0at 10:50 AM EST\u00a0on\u00a0Thursday, January 14, 2021. A live audio webcast of the presentation and archive for replay will be available on the Investor Relations section of Constellation\u2019s website at\u00a0http:\/\/ir.constellationpharma.com\/events-and-presentations\/events. The audio webcast replay will be available for 30 days following the live presentation. About Constellation Pharmaceuticals\u00a0 Constellation Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel therapeutics that selectively modulate gene expression to address serious unmet medical needs in patients with cancer. The Company has a deep understanding of how epigenetic and chromatin modifications in cancer cells and in the tumor and immune microenvironment &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/constellation-pharmaceuticals-to-present-at-j-p-morgan-healthcare-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Constellation Pharmaceuticals to Present at J.P. Morgan Healthcare Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-409639","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Constellation Pharmaceuticals to Present at J.P. Morgan Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/constellation-pharmaceuticals-to-present-at-j-p-morgan-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Constellation Pharmaceuticals to Present at J.P. Morgan Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CAMBRIDGE,\u00a0Mass., Jan. 06, 2021 (GLOBE NEWSWIRE) &#8212; Constellation Pharmaceuticals, Inc. (Nasdaq: CNST) today announced that\u00a0Jigar Raythatha, CEO, will present a company overview at the\u00a0J.P. Morgan Healthcare Conference\u00a0at 10:50 AM EST\u00a0on\u00a0Thursday, January 14, 2021. A live audio webcast of the presentation and archive for replay will be available on the Investor Relations section of Constellation\u2019s website at\u00a0http:\/\/ir.constellationpharma.com\/events-and-presentations\/events. The audio webcast replay will be available for 30 days following the live presentation. About Constellation Pharmaceuticals\u00a0 Constellation Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel therapeutics that selectively modulate gene expression to address serious unmet medical needs in patients with cancer. The Company has a deep understanding of how epigenetic and chromatin modifications in cancer cells and in the tumor and immune microenvironment &hellip; Continue reading &quot;Constellation Pharmaceuticals to Present at J.P. Morgan Healthcare Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/constellation-pharmaceuticals-to-present-at-j-p-morgan-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-06T15:03:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTUzMiMzOTA3MTIyIzIxMjA4NjA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/constellation-pharmaceuticals-to-present-at-j-p-morgan-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/constellation-pharmaceuticals-to-present-at-j-p-morgan-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Constellation Pharmaceuticals to Present at J.P. Morgan Healthcare Conference\",\"datePublished\":\"2021-01-06T15:03:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/constellation-pharmaceuticals-to-present-at-j-p-morgan-healthcare-conference\\\/\"},\"wordCount\":237,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/constellation-pharmaceuticals-to-present-at-j-p-morgan-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMTUzMiMzOTA3MTIyIzIxMjA4NjA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/constellation-pharmaceuticals-to-present-at-j-p-morgan-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/constellation-pharmaceuticals-to-present-at-j-p-morgan-healthcare-conference\\\/\",\"name\":\"Constellation Pharmaceuticals to Present at J.P. Morgan Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/constellation-pharmaceuticals-to-present-at-j-p-morgan-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/constellation-pharmaceuticals-to-present-at-j-p-morgan-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMTUzMiMzOTA3MTIyIzIxMjA4NjA=\",\"datePublished\":\"2021-01-06T15:03:15+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/constellation-pharmaceuticals-to-present-at-j-p-morgan-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/constellation-pharmaceuticals-to-present-at-j-p-morgan-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/constellation-pharmaceuticals-to-present-at-j-p-morgan-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMTUzMiMzOTA3MTIyIzIxMjA4NjA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMTUzMiMzOTA3MTIyIzIxMjA4NjA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/constellation-pharmaceuticals-to-present-at-j-p-morgan-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Constellation Pharmaceuticals to Present at J.P. Morgan Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Constellation Pharmaceuticals to Present at J.P. Morgan Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/constellation-pharmaceuticals-to-present-at-j-p-morgan-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Constellation Pharmaceuticals to Present at J.P. Morgan Healthcare Conference - Market Newsdesk","og_description":"CAMBRIDGE,\u00a0Mass., Jan. 06, 2021 (GLOBE NEWSWIRE) &#8212; Constellation Pharmaceuticals, Inc. (Nasdaq: CNST) today announced that\u00a0Jigar Raythatha, CEO, will present a company overview at the\u00a0J.P. Morgan Healthcare Conference\u00a0at 10:50 AM EST\u00a0on\u00a0Thursday, January 14, 2021. A live audio webcast of the presentation and archive for replay will be available on the Investor Relations section of Constellation\u2019s website at\u00a0http:\/\/ir.constellationpharma.com\/events-and-presentations\/events. The audio webcast replay will be available for 30 days following the live presentation. About Constellation Pharmaceuticals\u00a0 Constellation Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel therapeutics that selectively modulate gene expression to address serious unmet medical needs in patients with cancer. The Company has a deep understanding of how epigenetic and chromatin modifications in cancer cells and in the tumor and immune microenvironment &hellip; Continue reading \"Constellation Pharmaceuticals to Present at J.P. Morgan Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/constellation-pharmaceuticals-to-present-at-j-p-morgan-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-06T15:03:15+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTUzMiMzOTA3MTIyIzIxMjA4NjA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/constellation-pharmaceuticals-to-present-at-j-p-morgan-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/constellation-pharmaceuticals-to-present-at-j-p-morgan-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Constellation Pharmaceuticals to Present at J.P. Morgan Healthcare Conference","datePublished":"2021-01-06T15:03:15+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/constellation-pharmaceuticals-to-present-at-j-p-morgan-healthcare-conference\/"},"wordCount":237,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/constellation-pharmaceuticals-to-present-at-j-p-morgan-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTUzMiMzOTA3MTIyIzIxMjA4NjA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/constellation-pharmaceuticals-to-present-at-j-p-morgan-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/constellation-pharmaceuticals-to-present-at-j-p-morgan-healthcare-conference\/","name":"Constellation Pharmaceuticals to Present at J.P. Morgan Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/constellation-pharmaceuticals-to-present-at-j-p-morgan-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/constellation-pharmaceuticals-to-present-at-j-p-morgan-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTUzMiMzOTA3MTIyIzIxMjA4NjA=","datePublished":"2021-01-06T15:03:15+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/constellation-pharmaceuticals-to-present-at-j-p-morgan-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/constellation-pharmaceuticals-to-present-at-j-p-morgan-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/constellation-pharmaceuticals-to-present-at-j-p-morgan-healthcare-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTUzMiMzOTA3MTIyIzIxMjA4NjA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTUzMiMzOTA3MTIyIzIxMjA4NjA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/constellation-pharmaceuticals-to-present-at-j-p-morgan-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Constellation Pharmaceuticals to Present at J.P. Morgan Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/409639","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=409639"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/409639\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=409639"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=409639"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=409639"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}